QUEST DIAGNOSTICS
-
Labcorp beats quarterly profit estimate on diagnostic test demand
"While the macroeconomic environment remains dynamic, the critical nature of the work we do in diagnostics and drug development positions us well for success in 2025 and beyond," CEO Adam Schechter said.
-
Quest beats quarterly profit estimates on strong demand for diagnostic tests
-
US lab operator Quest Diagnostics to launch bird flu test at end of October
-
Diagnostics firm Labcorp weighs ramping up mpox testing capacity
-
Quest Diagnostics raises 2024 profit and revenue forecast on strong demand
-
Quest Diagnostics beats profit estimates as routine testing demand returns
-
FDA approves Quest COVID-19 test for 'pooled' sample use
-
Strand Life Sciences Acquires India Diagnostics Business from Quest Diagnostics
-
Health app hacked, data of 34,000 US patients out
Advertisement
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
